LCM
XERS icon

Legato Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Legato Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Sell
234,144
-3,287
-1% -$21.8K 0.12% 223
2025
Q4 		$1.86M Buy
237,431
+20,626
+10% +$162K 0.16% 196
2025
Q3 		$1.76M Hold
216,805
– – 0.19% 157
2025
Q2 		$1.01M Sell
216,805
-513
-0.2% -$2.35K 0.12% 274
2025
Q1 		$1.19M Buy
217,318
+75,154
+53% +$303K 0.16% 206
2024
Q4 		$482K Buy
+142,164
New +$457K 0.06% 443

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legato Capital Management's XERS Position: Q1 2026 in Review

Legato Capital Management reduced its Xeris Biopharma Holdings (XERS) stake by 1.4% in Q1 2026, selling an estimated $21.8K and leaving 234,144 shares worth $1.36M. The position accounts for 0.12% of the portfolio, ranked #223.

Legato Capital Management first reported a position in XERS in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.86M in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Legato Capital Management held 234,144 shares of Xeris Biopharma Holdings worth $1.36M as of Q1 2026.
  • Legato Capital Management sold 3,287 Xeris Biopharma Holdings shares in Q1 2026, an estimated $21.8K.
  • Xeris Biopharma Holdings made up 0.12% of Legato Capital Management's portfolio in Q1 2026, its #223 holding.
  • Legato Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 6 quarters since.
  • Legato Capital Management's Xeris Biopharma Holdings position peaked at $1.86M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.